Tubulis GmbH Company Contacts

Tubulis GmbH

http://www.tubulis.com
Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Our goal is to expand the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. We will... Read More
Contacts

Country

Germany

City

Munich

Headquarters

Munich, Bayern

Profile

Industry

Biotechnology Research

Size

51 - 200

Specialties

Antibody Drug Conjugates, Targeted Therapy, Biotechnology, Drug Development

Funding

Total Rounds

4

Last Round

Wed Mar 13 2024

Last Round Series

Series B

Last Round Raised

$ 139,300,472